"sample_name"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mss"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"batch_1"	"batch_2"	"batch_3"	"drug_name"	"drug_treatment"	"drug_response"	"uncurated_author_metadata"
"GSM712573"	"colorectal cancer sample AUS2_003_p348 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_003_p348 [exon-level]///geo_accession: GSM712573///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 2.6///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712573/GSM712573_AUS2_003_p348_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712398 (gene-level)"
"GSM712574"	"colorectal cancer sample AUS2_010_p1622 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_010_p1622 [exon-level]///geo_accession: GSM712574///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.97///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712574/GSM712574_AUS2_010_p1622_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712399 (gene-level)"
"GSM712575"	"colorectal cancer sample AUS2_011_p423 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_011_p423 [exon-level]///geo_accession: GSM712575///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.96///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712575/GSM712575_AUS2_011_p423_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712400 (gene-level)"
"GSM712576"	"colorectal cancer sample AUS2_012_p336 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_012_p336 [exon-level]///geo_accession: GSM712576///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.95///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712576/GSM712576_AUS2_012_p336_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712401 (gene-level)"
"GSM712577"	"colorectal cancer sample AUS2_013_p874 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_013_p874 [exon-level]///geo_accession: GSM712577///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.94///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712577/GSM712577_AUS2_013_p874_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712402 (gene-level)"
"GSM712578"	"colorectal cancer sample AUS2_017_p296 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_017_p296 [exon-level]///geo_accession: GSM712578///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.76///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712578/GSM712578_AUS2_017_p296_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712403 (gene-level)"
"GSM712579"	"colorectal cancer sample AUS2_018_p1355 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_018_p1355 [exon-level]///geo_accession: GSM712579///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.91///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712579/GSM712579_AUS2_018_p1355_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712404 (gene-level)"
"GSM712580"	"colorectal cancer sample AUS2_019_p312 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_019_p312 [exon-level]///geo_accession: GSM712580///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.74///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712580/GSM712580_AUS2_019_p312_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712405 (gene-level)"
"GSM712581"	"colorectal cancer sample AUS2_022_p452 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_022_p452 [exon-level]///geo_accession: GSM712581///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 4.65///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712581/GSM712581_AUS2_022_p452_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712406 (gene-level)"
"GSM712582"	"colorectal cancer sample AUS2_024_p280 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_024_p280 [exon-level]///geo_accession: GSM712582///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.67///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712582/GSM712582_AUS2_024_p280_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712407 (gene-level)"
"GSM712583"	"colorectal cancer sample AUS2_026_p473 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_026_p473 [exon-level]///geo_accession: GSM712583///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.62///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712583/GSM712583_AUS2_026_p473_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712408 (gene-level)"
"GSM712584"	"colorectal cancer sample AUS2_027_p876 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_027_p876 [exon-level]///geo_accession: GSM712584///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.17///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712584/GSM712584_AUS2_027_p876_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712409 (gene-level)"
"GSM712585"	"colorectal cancer sample AUS2_028_p256 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_028_p256 [exon-level]///geo_accession: GSM712585///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.59///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712585/GSM712585_AUS2_028_p256_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712410 (gene-level)"
"GSM712586"	"colorectal cancer sample AUS2_029_p476 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_029_p476 [exon-level]///geo_accession: GSM712586///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712586/GSM712586_AUS2_029_p476_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712411 (gene-level)"
"GSM712587"	"colorectal cancer sample AUS2_030_p340 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_030_p340 [exon-level]///geo_accession: GSM712587///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.56///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712587/GSM712587_AUS2_030_p340_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712412 (gene-level)"
"GSM712588"	"colorectal cancer sample AUS2_031_p478 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_031_p478 [exon-level]///geo_accession: GSM712588///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 2.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712588/GSM712588_AUS2_031_p478_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712413 (gene-level)"
"GSM712589"	"colorectal cancer sample AUS2_036_p504 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_036_p504 [exon-level]///geo_accession: GSM712589///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.04///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712589/GSM712589_AUS2_036_p504_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712414 (gene-level)"
"GSM712590"	"colorectal cancer sample AUS2_037_p304 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_037_p304 [exon-level]///geo_accession: GSM712590///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.47///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712590/GSM712590_AUS2_037_p304_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712415 (gene-level)"
"GSM712591"	"colorectal cancer sample AUS2_038_p249 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_038_p249 [exon-level]///geo_accession: GSM712591///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.47///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712591/GSM712591_AUS2_038_p249_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712416 (gene-level)"
"GSM712592"	"colorectal cancer sample AUS2_041_p260 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_041_p260 [exon-level]///geo_accession: GSM712592///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.22///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712592/GSM712592_AUS2_041_p260_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712417 (gene-level)"
"GSM712593"	"colorectal cancer sample AUS2_042_p506 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_042_p506 [exon-level]///geo_accession: GSM712593///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 1.95///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712593/GSM712593_AUS2_042_p506_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712418 (gene-level)"
"GSM712594"	"colorectal cancer sample AUS2_043_p1327 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_043_p1327 [exon-level]///geo_accession: GSM712594///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.81///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712594/GSM712594_AUS2_043_p1327_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712419 (gene-level)"
"GSM712595"	"colorectal cancer sample AUS2_044_p268 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_044_p268 [exon-level]///geo_accession: GSM712595///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.35///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712595/GSM712595_AUS2_044_p268_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712420 (gene-level)"
"GSM712596"	"colorectal cancer sample AUS2_048_p344 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_048_p344 [exon-level]///geo_accession: GSM712596///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.08///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712596/GSM712596_AUS2_048_p344_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712421 (gene-level)"
"GSM712597"	"colorectal cancer sample AUS2_050_p533 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_050_p533 [exon-level]///geo_accession: GSM712597///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.33///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712597/GSM712597_AUS2_050_p533_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712422 (gene-level)"
"GSM712598"	"colorectal cancer sample AUS2_051_p1596 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_051_p1596 [exon-level]///geo_accession: GSM712598///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.97///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712598/GSM712598_AUS2_051_p1596_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712423 (gene-level)"
"GSM712599"	"colorectal cancer sample AUS2_053_p328 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_053_p328 [exon-level]///geo_accession: GSM712599///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 0.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712599/GSM712599_AUS2_053_p328_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712424 (gene-level)"
"GSM712600"	"colorectal cancer sample AUS2_054_p272 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_054_p272 [exon-level]///geo_accession: GSM712600///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.1///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712600/GSM712600_AUS2_054_p272_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712425 (gene-level)"
"GSM712601"	"colorectal cancer sample AUS2_055_p536 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_055_p536 [exon-level]///geo_accession: GSM712601///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.28///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712601/GSM712601_AUS2_055_p536_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712426 (gene-level)"
"GSM712602"	"colorectal cancer sample AUS2_058_p538 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_058_p538 [exon-level]///geo_accession: GSM712602///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.52///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712602/GSM712602_AUS2_058_p538_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712427 (gene-level)"
"GSM712603"	"colorectal cancer sample AUS2_065_p551 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_065_p551 [exon-level]///geo_accession: GSM712603///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.17///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712603/GSM712603_AUS2_065_p551_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712428 (gene-level)"
"GSM712604"	"colorectal cancer sample AUS2_068_p564 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_068_p564 [exon-level]///geo_accession: GSM712604///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.13///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712604/GSM712604_AUS2_068_p564_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712429 (gene-level)"
"GSM712605"	"colorectal cancer sample AUS2_070_p566 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_070_p566 [exon-level]///geo_accession: GSM712605///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.54///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712605/GSM712605_AUS2_070_p566_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712430 (gene-level)"
"GSM712606"	"colorectal cancer sample AUS2_072_p590 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_072_p590 [exon-level]///geo_accession: GSM712606///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.11///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712606/GSM712606_AUS2_072_p590_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712431 (gene-level)"
"GSM712607"	"colorectal cancer sample AUS2_075_p595 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_075_p595 [exon-level]///geo_accession: GSM712607///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.05///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712607/GSM712607_AUS2_075_p595_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712432 (gene-level)"
"GSM712608"	"colorectal cancer sample AUS2_084_p622 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_084_p622 [exon-level]///geo_accession: GSM712608///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712608/GSM712608_AUS2_084_p622_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712433 (gene-level)"
"GSM712609"	"colorectal cancer sample AUS2_086_p624 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_086_p624 [exon-level]///geo_accession: GSM712609///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.92///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712609/GSM712609_AUS2_086_p624_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712434 (gene-level)"
"GSM712610"	"colorectal cancer sample AUS2_089_p645 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_089_p645 [exon-level]///geo_accession: GSM712610///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 2.17///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712610/GSM712610_AUS2_089_p645_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712435 (gene-level)"
"GSM712611"	"colorectal cancer sample AUS2_090_p646 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_090_p646 [exon-level]///geo_accession: GSM712611///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712611/GSM712611_AUS2_090_p646_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712436 (gene-level)"
"GSM712612"	"colorectal cancer sample AUS2_091_p647 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_091_p647 [exon-level]///geo_accession: GSM712612///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712612/GSM712612_AUS2_091_p647_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712437 (gene-level)"
"GSM712613"	"colorectal cancer sample AUS2_092_p648 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_092_p648 [exon-level]///geo_accession: GSM712613///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.87///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712613/GSM712613_AUS2_092_p648_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712438 (gene-level)"
"GSM712614"	"colorectal cancer sample AUS2_093_p649 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_093_p649 [exon-level]///geo_accession: GSM712614///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.7///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712614/GSM712614_AUS2_093_p649_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712439 (gene-level)"
"GSM712615"	"colorectal cancer sample AUS2_094_p640 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_094_p640 [exon-level]///geo_accession: GSM712615///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.86///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712615/GSM712615_AUS2_094_p640_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712440 (gene-level)"
"GSM712616"	"colorectal cancer sample AUS2_096_p652 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_096_p652 [exon-level]///geo_accession: GSM712616///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.84///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712616/GSM712616_AUS2_096_p652_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712441 (gene-level)"
"GSM712617"	"colorectal cancer sample AUS2_097_p643 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_097_p643 [exon-level]///geo_accession: GSM712617///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.86///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712617/GSM712617_AUS2_097_p643_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712442 (gene-level)"
"GSM712618"	"colorectal cancer sample AUS2_098_p665 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_098_p665 [exon-level]///geo_accession: GSM712618///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.85///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712618/GSM712618_AUS2_098_p665_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712443 (gene-level)"
"GSM712619"	"colorectal cancer sample AUS2_100_p668 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_100_p668 [exon-level]///geo_accession: GSM712619///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.84///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712619/GSM712619_AUS2_100_p668_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712444 (gene-level)"
"GSM712620"	"colorectal cancer sample AUS2_114_p1356 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_114_p1356 [exon-level]///geo_accession: GSM712620///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.69///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712620/GSM712620_AUS2_114_p1356_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712445 (gene-level)"
"GSM712621"	"colorectal cancer sample AUS2_117_p906_2 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_117_p906_2 [exon-level]///geo_accession: GSM712621///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.67///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712621/GSM712621_AUS2_117_p906_HuEx-1_0-st-v2_2.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712446 (gene-level)"
"GSM712622"	"colorectal cancer sample AUS2_118_p907 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_118_p907 [exon-level]///geo_accession: GSM712622///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.66///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712622/GSM712622_AUS2_118_p907_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712447 (gene-level)"
"GSM712623"	"colorectal cancer sample AUS2_119_p927 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_119_p927 [exon-level]///geo_accession: GSM712623///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.65///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712623/GSM712623_AUS2_119_p927_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712448 (gene-level)"
"GSM712624"	"colorectal cancer sample AUS2_123_p931 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_123_p931 [exon-level]///geo_accession: GSM712624///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.63///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712624/GSM712624_AUS2_123_p931_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712449 (gene-level)"
"GSM712625"	"colorectal cancer sample AUS2_127_p914 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_127_p914 [exon-level]///geo_accession: GSM712625///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.58///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712625/GSM712625_AUS2_127_p914_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712450 (gene-level)"
"GSM712626"	"colorectal cancer sample AUS2_129_p934 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_129_p934 [exon-level]///geo_accession: GSM712626///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.79///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712626/GSM712626_AUS2_129_p934_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712451 (gene-level)"
"GSM712627"	"colorectal cancer sample AUS2_130_p935 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_130_p935 [exon-level]///geo_accession: GSM712627///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.44///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712627/GSM712627_AUS2_130_p935_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712452 (gene-level)"
"GSM712628"	"colorectal cancer sample AUS2_134_p949 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_134_p949 [exon-level]///geo_accession: GSM712628///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.4///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712628/GSM712628_AUS2_134_p949_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712453 (gene-level)"
"GSM712629"	"colorectal cancer sample AUS2_140_p954 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_140_p954 [exon-level]///geo_accession: GSM712629///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.34///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712629/GSM712629_AUS2_140_p954_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712454 (gene-level)"
"GSM712630"	"colorectal cancer sample AUS2_144_p966 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_144_p966 [exon-level]///geo_accession: GSM712630///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.27///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712630/GSM712630_AUS2_144_p966_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712455 (gene-level)"
"GSM712631"	"colorectal cancer sample AUS2_145_p977 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_145_p977 [exon-level]///geo_accession: GSM712631///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.27///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712631/GSM712631_AUS2_145_p977_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712456 (gene-level)"
"GSM712632"	"colorectal cancer sample AUS2_147_p989 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_147_p989 [exon-level]///geo_accession: GSM712632///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.23///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712632/GSM712632_AUS2_147_p989_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712457 (gene-level)"
"GSM712633"	"colorectal cancer sample AUS2_153_p993 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_153_p993 [exon-level]///geo_accession: GSM712633///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.65///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712633/GSM712633_AUS2_153_p993_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712458 (gene-level)"
"GSM712634"	"colorectal cancer sample AUS2_158_p995 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_158_p995 [exon-level]///geo_accession: GSM712634///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.11///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712634/GSM712634_AUS2_158_p995_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712459 (gene-level)"
"GSM712635"	"colorectal cancer sample AUS2_165_p1011 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_165_p1011 [exon-level]///geo_accession: GSM712635///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.02///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712635/GSM712635_AUS2_165_p1011_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712460 (gene-level)"
"GSM712636"	"colorectal cancer sample AUS2_167_p1013 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_167_p1013 [exon-level]///geo_accession: GSM712636///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.02///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712636/GSM712636_AUS2_167_p1013_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712461 (gene-level)"
"GSM712637"	"colorectal cancer sample AUS2_169_p1014 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_169_p1014 [exon-level]///geo_accession: GSM712637///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712637/GSM712637_AUS2_169_p1014_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712462 (gene-level)"
"GSM712638"	"colorectal cancer sample AUS2_171_p1015 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_171_p1015 [exon-level]///geo_accession: GSM712638///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712638/GSM712638_AUS2_171_p1015_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712463 (gene-level)"
"GSM712639"	"colorectal cancer sample AUS2_175_p1471 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_175_p1471 [exon-level]///geo_accession: GSM712639///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.96///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712639/GSM712639_AUS2_175_p1471_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712464 (gene-level)"
"GSM712640"	"colorectal cancer sample AUS2_177_p1569 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_177_p1569 [exon-level]///geo_accession: GSM712640///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.94///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712640/GSM712640_AUS2_177_p1569_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712465 (gene-level)"
"GSM712641"	"colorectal cancer sample AUS2_182_p1478 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_182_p1478 [exon-level]///geo_accession: GSM712641///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 1.49///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712641/GSM712641_AUS2_182_p1478_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712466 (gene-level)"
"GSM712642"	"colorectal cancer sample AUS2_183_p1575 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_183_p1575 [exon-level]///geo_accession: GSM712642///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.9///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712642/GSM712642_AUS2_183_p1575_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712467 (gene-level)"
"GSM712643"	"colorectal cancer sample AUS2_184_p1576 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_184_p1576 [exon-level]///geo_accession: GSM712643///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712643/GSM712643_AUS2_184_p1576_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712468 (gene-level)"
"GSM712644"	"colorectal cancer sample AUS2_185_p1577 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_185_p1577 [exon-level]///geo_accession: GSM712644///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712644/GSM712644_AUS2_185_p1577_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712469 (gene-level)"
"GSM712645"	"colorectal cancer sample AUS2_186_p1482 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_186_p1482 [exon-level]///geo_accession: GSM712645///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712645/GSM712645_AUS2_186_p1482_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712470 (gene-level)"
"GSM712646"	"colorectal cancer sample AUS2_187_p1579 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_187_p1579 [exon-level]///geo_accession: GSM712646///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.5///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712646/GSM712646_AUS2_187_p1579_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712471 (gene-level)"
"GSM712647"	"colorectal cancer sample AUS2_190_p1486 [exon-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_190_p1486 [exon-level]///geo_accession: GSM712647///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.84///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712647/GSM712647_AUS2_190_p1486_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712472 (gene-level)"
"GSM712648"	"colorectal cancer sample AUS2_197_p1588 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_197_p1588 [exon-level]///geo_accession: GSM712648///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.76///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712648/GSM712648_AUS2_197_p1588_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712473 (gene-level)"
"GSM712649"	"colorectal cancer sample AUS2_200_p1591 [exon-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: colorectal cancer sample AUS2_200_p1591 [exon-level]///geo_accession: GSM712649///status: Public on May 19 2011///submission_date: Apr 21 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.75///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL11028///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712649/GSM712649_AUS2_200_p1591_HuEx-1_0-st-v2_.CEL.gz///data_row_count: 284258///relation: Alternative to: GSM712474 (gene-level)"
